280 related articles for article (PubMed ID: 31559570)
1. Blood Pressure Variability and Therapeutic Implications in Hypertension and Cardiovascular Diseases.
Nardin C; Rattazzi M; Pauletto P
High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):353-359. PubMed ID: 31559570
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
[TBL] [Abstract][Full Text] [Related]
3. Does Antihypertensive Drug Class Affect Day-to-Day Variability of Self-Measured Home Blood Pressure? The HOMED-BP Study.
Asayama K; Ohkubo T; Hanazawa T; Watabe D; Hosaka M; Satoh M; Yasui D; Staessen JA; Imai Y;
J Am Heart Assoc; 2016 Mar; 5(3):e002995. PubMed ID: 27009620
[TBL] [Abstract][Full Text] [Related]
4. Effects of Antihypertensive Therapy on Blood Pressure Variability.
Eguchi K
Curr Hypertens Rep; 2016 Oct; 18(10):75. PubMed ID: 27699587
[TBL] [Abstract][Full Text] [Related]
5. Blood Pressure Variability: Assessment, Prognostic Significance and Management.
Chenniappan M
J Assoc Physicians India; 2015 May; 63(5):47-53. PubMed ID: 26591145
[TBL] [Abstract][Full Text] [Related]
6. Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment.
Omboni S; Kario K; Bakris G; Parati G
J Hypertens; 2018 Apr; 36(4):720-733. PubMed ID: 29045341
[TBL] [Abstract][Full Text] [Related]
7. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
8. Drugs affecting blood pressure variability: an update.
Hocht C; Del Mauro JS; Bertera FM; Taira CA
Curr Pharm Des; 2015; 21(6):744-55. PubMed ID: 25341858
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure variability: its measurement and significance in hypertension.
Parati G; Faini A; Valentini M
Curr Hypertens Rep; 2006 Jun; 8(3):199-204. PubMed ID: 17147917
[TBL] [Abstract][Full Text] [Related]
10. Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
Wang JG; Yan P; Jeffers BW
J Am Soc Hypertens; 2014 May; 8(5):340-9. PubMed ID: 24685006
[TBL] [Abstract][Full Text] [Related]
11. Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.
Zhang L; Yang J; Li L; Liu D; Xie X; Dong P; Lin Y
J Comp Eff Res; 2018 Jul; 7(7):651-660. PubMed ID: 29888950
[TBL] [Abstract][Full Text] [Related]
12. Is It Daily, Monthly, or Yearly Blood Pressure Variability that Enhances Cardiovascular Risk?
Dolan E; O'Brien E
Curr Cardiol Rep; 2015 Nov; 17(11):93. PubMed ID: 26351017
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
[TBL] [Abstract][Full Text] [Related]
15. Effects of doxazosin mesylate versus nifedipine on blood pressure variability in hypertensive patients: a randomized crossover study (SIMILAR).
Shi J; Liang D; Pan Y; Zhang S; He M; Zhang H; Liu G; Gong Y; Wang W; Cang H; Li Y
Blood Press Monit; 2019 Oct; 24(5):252-258. PubMed ID: 31116151
[TBL] [Abstract][Full Text] [Related]
16. Hypertension and blood pressure variability management practices among physicians in Singapore.
Setia S; Subramaniam K; Tay JC; Teo BW
Vasc Health Risk Manag; 2017; 13():275-285. PubMed ID: 28761353
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
Antza C; Stabouli S; Kotsis V
Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
Ulusoy S; Ozkan G; Konca C; Kaynar K
Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
[TBL] [Abstract][Full Text] [Related]
19. Predictors of visit-to-visit blood pressure variability in patients with hypertension: an analysis of trials with an amlodipine treatment arm.
Wang JG; Zhou D; Jeffers BW
J Am Soc Hypertens; 2017 Jul; 11(7):402-411. PubMed ID: 28624170
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination.
Parati G; Schumacher H
Hypertens Res; 2014 Mar; 37(3):187-93. PubMed ID: 24305518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
